Study to Evaluate the Effect of a Vegetal Oil on Cognitive Impairment
NCT02778581 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 110
Last updated 2016-06-03
Summary
The aim of the study is to evaluate the beneficial effect of a mixture of vegetal oils with a composition related to short, medium and long unsaturated chain fatty acids on patients with a diagnose of cognitive impairment or mild to moderate Alzheimer disease
Conditions
- Cognitive Impairments
- Alzheimer Disease
Interventions
- DIETARY_SUPPLEMENT
-
Lipidic Blend 1
daily intake of the content of one 45 mL bottle containing the product
- DIETARY_SUPPLEMENT
-
Lipidic Blend 2
daily intake of the content of one 45 mL bottle containing the product
- DIETARY_SUPPLEMENT
-
Placebo
daily intake of the content of one 45 mL bottle containing olive oil
Sponsors & Collaborators
-
Biopolis S.L.
collaborator INDUSTRY -
Team Foods Colombia S.A.
lead INDUSTRY
Principal Investigators
-
Vicente Navarro-López, MD · Universidad Católica San Antonio de Murcia
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 55 Years
- Max Age
- 85 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-03-31
- Primary Completion
- 2017-04-30
- Completion
- 2017-07-31
Countries
- Spain
Study Locations
More Related Trials
-
Effects of a Nutraceutic Compound on Cognitive Impairment
NCT06200883 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety of PRJ212 to Improve the Memory of Patients With Mild Severity Alzheimer's Disease
NCT02991235 ·Status: UNKNOWN ·Phase: NA
-
Effects of Triglycerides on Age-Related Cognitive Function Decline in Older Subjects
NCT01702480 ·Status: COMPLETED ·Phase: PHASE1
-
CBD for Individuals at Risk for Alzheimer's Disease
NCT05822362 ·Status: RECRUITING ·Phase: PHASE2
-
Management of Mild Cognitive Impairment Patients With Extra Virgin Olive Oil - MICOIL
NCT03362996 ·Status: UNKNOWN ·Phase: PHASE2
-
Effect of Consuming a Mixture of Extracts and DHA on the Mild Cognitive Impairment
NCT06254040 ·Status: COMPLETED ·Phase: NA
-
Modulation of Abeta Levels by GSK933776 in Alzheimer's Disease Patient
NCT01424436 ·Status: COMPLETED ·Phase: PHASE1
-
Tributyrin Treatment in Mild Alzheimer Disease: Assessment of Butyrate Effects Via the Gut-Brain
NCT06797817 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Cytokines and Cognitive Decline in Alzheimer's Disease
NCT01351142 ·Status: COMPLETED ·Phase: NA
-
Effects of THC-Free CBD Oil on Agitation in Patients With Alzheimer's Disease
NCT04436081 ·Status: UNKNOWN ·Phase: PHASE2
-
Investigating a Phosphatidylserine Based Dietary Approach for the Management of Mild Cognitive Impairment
NCT02211560 ·Status: TERMINATED ·Phase: NA
-
Food Effect Study of BMS-984923 in Healthy Older Adult Volunteers
NCT05817643 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Cannabidiol's Role in Dementia Management
NCT06514066 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2/PHASE3
-
Efficacy and Safety of ChOline ALfoscerate in Patient With Mild to Moderate Alzheimer's Disease
NCT05383183 ·Status: RECRUITING ·Phase: PHASE4
-
Study to Assess Adverse Events, Change in Disease Activity and How Oral ABBV-552 Capsules Moves Through the Body of Participants Aged 50 to 90 Years With Mild Alzheimer's Disease
NCT05771428 ·Status: COMPLETED ·Phase: PHASE2
-
Non-pharmacological Intervention for Preclinical Alzheimer's Disease
NCT04279418 ·Status: COMPLETED ·Phase: NA
-
Effects of Sulforaphane in Patients With Prodromal to Mild Alzheimer's Disease
NCT04213391 ·Status: UNKNOWN ·Phase: NA
-
Evaluate the Efficacy and Safety of ID1201 for Dose-finding in Mild Alzheimer's Disease
NCT03363269 ·Status: COMPLETED ·Phase: PHASE2
-
Metabolic Cofactor Supplementation in Alzheimer's Disease (AD) and Parkinson's Disease (PD) Patients
NCT04044131 ·Status: COMPLETED ·Phase: PHASE2
-
Effects of Pomegranate Seed Oil and Mediterranean Diet on MCI
NCT04990362 ·Status: UNKNOWN ·Phase: NA
-
Design of Personalised SupplemenTs Based on the Gut MicRobiota Through Artificial Intelligence for Alzheimer's Patients
NCT06199193 ·Status: RECRUITING ·Phase: NA
-
Evaluating Effect of the Study Drug Praluent (Alirocumab) on Neurocognitive Function When Compared to Placebo
NCT02957682 ·Status: COMPLETED ·Phase: PHASE4
-
Influence of Oxidative Stress and Nutrition Biomarkers on the Cognitive Decline Evolution in Alzheimer Disease
NCT02800395 ·Status: RECRUITING ·Phase: NA
-
Use of a Cannabinoids as a Treatment Strategy for Alzheimer's Disease
NCT06570928 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluate the Efficacy and Safety of ABT-126 in Subjects With Mild to Moderate Alzheimer's Disease
NCT01527916 ·Status: COMPLETED ·Phase: PHASE2